Thai PBS Thai PBS
Covid jab maker BioNTech to build SE Asia manufacturing site in Singapore

Covid jab maker BioNTech to build SE Asia manufacturing site in Singapore

13 Sept 07:54 Key points summarised by AI
  • BioNTech announced plans to build its first Southeast Asia headquarters and mRNA manufacturing site in Singapore.
  • The new facility, expected to be operational by 2023, will produce hundreds of millions of mRNA-based vaccines annually.
  • This strategic expansion aims to significantly increase BioNTech's global network capacity for manufacturing and delivering mRNA vaccines and therapies.
Read full article
World 1/2
Skip > Skip >